HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis. - Wikidata - awgldk - TriplyDB

HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.

HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.

http://www.wikidata.org/entity/Q37522215

about

Role of nitric oxide in the pathogenesis of Barrett's-associated carcinogenesis Systematic review and meta-analysis of immunohistochemical prognostic biomarkers in resected oesophageal adenocarcinoma Multi-colour FISH in oesophageal adenocarcinoma-predictors of prognosis independent of stage and grade HER2 expression in gastric and oesophageal cancer: a meta-analytic review Loss of SRY-box2 (SOX2) expression and its impact on survival of patients with oesophageal adenocarcinoma.Genomics of Esophageal Cancer and Biomarkers for Early Detection.Hyperinsulinemia Promotes Esophageal Cancer Development in a Surgically-Induced Duodeno-Esophageal Reflux Murine Model.Association of sporadic and familial Barrett's esophagus with breast cancer.

P2860

Q26766641-063390AA-58E1-476E-A5B9-0E7B682FB58A Q28085367-2A43193F-9FCA-43C9-BDD8-D2C532EC0055 Q33750142-6A5776A9-967D-4EDB-BA82-0E7DD35225A2 Q35029025-27677C7F-264F-493F-B810-7A17909E3FB2 Q38686553-F1195CBA-62CE-4EBD-8A39-9F2D1DC03E3B Q38940530-AB59441E-DEA2-4274-AA2F-3B9B83537784 Q52584667-2EEFF96A-31D1-46D8-9929-0F4BC33455DF Q52661117-3C6B1379-4AF8-4FDF-9358-9D513668EC87

P2860

HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.

http://www.wikidata.org/entity/Q37522215

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on February 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.

@en

HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.

@nl

type

label

HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.

@en

HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.

@nl

prefLabel

HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.

@en

HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.

@nl

P1433

Q37522215-44AA3A26-E6C0-4168-8FA5-FC5E66CF9EA9

P1476

Q37522215-7E7A2763-1E93-402C-B847-A639D5044DA8

P2093

Q37522215-12C217D2-2748-4F17-A0AA-899BA99D35D4

Q37522215-345AD556-2410-4027-8BCC-1C23169E0D14

Q37522215-AFCE7BC0-EBD8-4F00-ABBE-4BDA86EE86A6

P2860

Q37522215-0661E358-6A6C-42FB-8933-3CF8A9D6F791

Q37522215-0979CEC7-BE99-4DFE-A9E3-11A46C379F26

Q37522215-0F00230D-AB1C-4DD3-8571-0FA17241E8C1

Q37522215-190AF68D-E3B7-45EC-B994-5542EEF33A0A

Q37522215-1A9AA547-D2FB-4983-A690-DA513AF1128F

Q37522215-1CACAD65-578B-4E58-877C-A9AA219A2A06

Q37522215-24BA7546-C5AC-4C07-8237-E1EB89EF2B7E

Q37522215-2BEEECF8-D2BC-402E-87E9-C7CC45F440D9

Q37522215-36BA9ED3-0BB1-41BB-AB84-389957BDFEB7

Q37522215-39ADA9D0-1158-4783-BA0E-9FED3CD0D3DC

P304

Q37522215-9FD58CE7-B8CB-44FA-91FD-9F4A49DAFB41

P31

Q37522215-7EF5B970-B2AC-49FC-94A6-8E0A5C814E12

P356

Q37522215-D85ADE44-644E-4B1C-AE99-4F1D1DE230B9

P433

Q37522215-AE1BFDDB-11B4-4D48-B13B-512C76217BDF

P478

Q37522215-B30CE0BB-76A9-4C90-9C9B-E11DD13462E3

P577

Q37522215-E38314D3-53F0-46E7-993F-E13C678567BA

P698

Q37522215-DDCBC94C-67AF-4C3E-A734-8018461AB285

P921

Q37522215-A5E69C70-BF7E-4BD8-AB25-921A0CF8BAD6

P932

Q37522215-C52C8C83-8E72-4D5A-BDFC-A9DF203CC771

P356

J.ISSN.2078-6891.2013.039

P1433

Journal of gastrointestinal oncology

P1476

HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.

@en

P2093

Ashwini Gowryshankar

http://www.w3.org/2001/XMLSchema#string

Guy D Eslick

http://www.w3.org/2001/XMLSchema#string

Vinayak Nagaraja

http://www.w3.org/2001/XMLSchema#string

P2860

Role of epigenetic alterations in the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma

Bias in meta-analysis detected by a simple, graphical test

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Measuring inconsistency in meta-analyses

Meta-analysis in clinical trials

CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma

Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.

Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients.

Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry

TOPOIIalpha and HER-2/neu overexpression/amplification in Barrett's oesophagus, dysplasia and adenocarcinoma

P304

25-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2078-6891.2013.039

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24490040

http://www.w3.org/2001/XMLSchema#string

P921

P932

3904023

http://www.w3.org/2001/XMLSchema#string